KITS EYECARE LTD Aktie

Kits Eyecare reports Q1 2026 revenue of CAD 57.5m, below analysts' estimate of CAD 59.12m, after which the stock fell about 13.6%. The eyewear segment rose 61% to CAD 10.8m and helped drive record profitability; adjusted EBITDA was CAD 4.1m (7.2% margin). The company is debt-free and holds CAD 37m in liquidity, but guides only CAD 57–59m revenue for Q2 and a significantly lower adjusted EBITDA margin of 3–5%, raising investor concerns about slowing growth and higher marketing spend. » More on de.investing.com

Kits Eyecare reported revenue of CAD 57.5m for Q1 2026, a shortfall of 2.8% versus expectations, while EPS of CAD 0.0523 slightly beat the forecast by 4.6%. The eyewear segment grew 61% year‑over‑year and drove overall revenue growth of 23%; the company also reported improved gross margin and a record adjusted EBITDA of CAD 4.1m. Despite profitability, the stock fell about 13.6% in premarket trading as investors viewed the missed revenue targets as a risk to future growth. Management cited further growth in the eyewear segment and expansion plans as key levers to secure guidance. » More on de.investing.com

Kits Eyecare posted record revenue of CAD 53.9m in Q4 2025, beating the CAD 52.95m forecast. Revenue rose 20% year‑over‑year, adjusted EBITDA was CAD 2.8m, and the company closed the year with no long‑term debt. The stock climbed 4.13% to CAD 18.17 after the results; the company remains adjusted profitable for the 13th consecutive quarter. For Q1 2026 Kits Eyecare forecasts CAD 10.5m in the eyewear segment and CAD 48m in the contact lens segment, supported by strong growth of the KITS Dailies brand (316% in Q4). » More on de.investing.com